Overview

Comparison Atomoxetine Hydrochloride and Comparator in Pediatric Outpatients With ADHD

Status:
Completed
Trial end date:
2004-10-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to compare atomoxetine hydrochloride and methylphenidate hydrochloride in pediatric patients with ADHD.
Phase:
Phase 3
Details
Lead Sponsor:
Eli Lilly and Company
Treatments:
Atomoxetine Hydrochloride
Methylphenidate